A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
mediaposted on 09.05.2021, 19:35 by Adis journals on behalf of, Andreas Andersen, Filip Krag Knop, Tina Vilsbøll
The above video abstract represents the opinions of
the authors. For a full list of declarations, including
funding and author disclosure statements, please see the full text online (see
“read the peer-reviewed publication” opposite).